Kevin S. Orwig

Array ( [id] => 18895193 [patent_doc_number] => 20240010678 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-11 [patent_title] => METHOD OF TREATMENT OF IRRITABLE BOWEL SYNDROME [patent_app_type] => utility [patent_app_number] => 18/025367 [patent_app_country] => US [patent_app_date] => 2021-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12580 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18025367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17426690 [patent_doc_number] => 20220054398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-24 [patent_title] => USE OF RUBUS FRUTICOSUS EXTRACT FOR MANUFACTURING A SKINCARE COMPOSITION [patent_app_type] => utility [patent_app_number] => 17/407190 [patent_app_country] => US [patent_app_date] => 2021-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8298 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17407190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18140142 [patent_doc_number] => 20230013981 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-19 [patent_title] => WATER-DISPERSIBLE DRY POWDER FORMULATION AND PRODUCTION METHOD THEREOF [patent_app_type] => utility [patent_app_number] => 17/372741 [patent_app_country] => US [patent_app_date] => 2021-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3015 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17372741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18692585 [patent_doc_number] => 20230322887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => GLP-1/GLUCAGON DUAL AGONIST FUSION PROTEIN [patent_app_type] => utility [patent_app_number] => 18/005898 [patent_app_country] => US [patent_app_date] => 2021-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7675 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18005898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17050505 [patent_doc_number] => 20210259939 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-26 [patent_title] => HAIR CARE CONDITIONING COMPOSITION COMPRISING HISTIDINE [patent_app_type] => utility [patent_app_number] => 17/318685 [patent_app_country] => US [patent_app_date] => 2021-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11902 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17318685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17228607 [patent_doc_number] => 20210355163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-18 [patent_title] => COMPOUNDS HAVING TRIPLE ACTIVITIES OF THROMBOLYSIS, ANTITHROMBOTIC AND RADICAL SCAVENGING [patent_app_type] => utility [patent_app_number] => 17/225775 [patent_app_country] => US [patent_app_date] => 2021-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18280 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17225775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19729586 [patent_doc_number] => RE050282 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2025-01-28 [patent_title] => Specific modification of antibody with IgG-binding peptide [patent_app_type] => reissue [patent_app_number] => 17/199255 [patent_app_country] => US [patent_app_date] => 2021-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 34 [patent_no_of_words] => 17681 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17199255 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16913921 [patent_doc_number] => 20210187013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => Methods of Treating and Preventing Cancer by Disrupting the Binding of Copper in the Map Kinase Pathway [patent_app_type] => utility [patent_app_number] => 17/144967 [patent_app_country] => US [patent_app_date] => 2021-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10177 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17144967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16749019 [patent_doc_number] => 20210101028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-08 [patent_title] => Endure, Anti-radiation supplement [patent_app_type] => utility [patent_app_number] => 17/122328 [patent_app_country] => US [patent_app_date] => 2020-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 69 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17122328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16628714 [patent_doc_number] => 20210047367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-18 [patent_title] => PREPARATION AND USES OF REACTIVE OXYGEN SPECIES SCAVENGER DERIVATIVES [patent_app_type] => utility [patent_app_number] => 17/086651 [patent_app_country] => US [patent_app_date] => 2020-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25122 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 332 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17086651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18273737 [patent_doc_number] => 11612658 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-03-28 [patent_title] => Oil-in-water emulsions comprising cetalkonium chloride and methods of making and using the same [patent_app_type] => utility [patent_app_number] => 16/949237 [patent_app_country] => US [patent_app_date] => 2020-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5197 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16949237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18642433 [patent_doc_number] => 11766486 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-09-26 [patent_title] => Methods of delivering anionic agents in vivo using non-viral nanoparticle-based delivery systems [patent_app_type] => utility [patent_app_number] => 17/069701 [patent_app_country] => US [patent_app_date] => 2020-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 67 [patent_no_of_words] => 25116 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 325 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17069701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16761068 [patent_doc_number] => 20210106649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-15 [patent_title] => SYNERGISTIC COMBINATION OF CHEMOTHERAPY AND PEPTIDE FOR TREATING CANCER [patent_app_type] => utility [patent_app_number] => 17/067751 [patent_app_country] => US [patent_app_date] => 2020-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9577 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17067751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16718603 [patent_doc_number] => 20210085750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-25 [patent_title] => PHAGE-PEPTIDE CONSTRUCTS FOR STIMULATION OF AN ANTI-CANCER IMMUNE RESPONSE AGAINST CD47 [patent_app_type] => utility [patent_app_number] => 17/031663 [patent_app_country] => US [patent_app_date] => 2020-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18805 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17031663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16671180 [patent_doc_number] => 20210059943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-04 [patent_title] => Systems and methods addressing multiple aspects to provide a comprehensive recovery program for addictions, chronic conditions and diseases [patent_app_type] => utility [patent_app_number] => 17/003251 [patent_app_country] => US [patent_app_date] => 2020-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9534 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17003251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16482439 [patent_doc_number] => 20200376039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-03 [patent_title] => ORAL DELIVERY OF THERAPEUTIC MAMMALIAN CELLS [patent_app_type] => utility [patent_app_number] => 16/996586 [patent_app_country] => US [patent_app_date] => 2020-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12452 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16996586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16742071 [patent_doc_number] => 10967040 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-06 [patent_title] => Methods of treating prader-willi syndrome with carbetocin [patent_app_type] => utility [patent_app_number] => 16/938257 [patent_app_country] => US [patent_app_date] => 2020-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15469 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16938257 [rel_patent_id] =>[rel_patent_doc_number] =>)